Evidence of populational Burkholderia pseudomallei exposure in Madagascar

Solohery Lalaina Razafimahatratra1, Sarobidy Tsiory Avotra Andriambinintsoa1, Lova Tsikiniaina Rasoloharimanana1

  • 1Immunology of Infectious Diseases, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

PubMed
Abstract

Insights

Human exposure to Burkholderia pseudomallei (Bp) occurs in Madagascar. Specific antigens HCP1 and CPS I show promise for diagnostics, with higher exposure in Mahajanga.

Area of Science:

  • Medical Microbiology
  • Immunology
  • Public Health

Background:

  • Burkholderia pseudomallei (Bp) causes melioidosis, a significant health risk in endemic areas.
  • Madagascar is a potential setting for Bp exposure, necessitating monitoring and diagnostic strategies.

Purpose of the Study:

  • Characterize six Bp antigens for exposure monitoring in Madagascar.
  • Assess regional Bp exposure and reactivity to inform diagnostics and understand patterns.

Main Methods:

  • Protein BLAST (BLASTp) used for antigen conservation and specificity analysis.
  • Luminex bead-based multiplex assays analyzed serological reactivity in 5,736 serum samples from six Malagasy regions.
  • Principal Component Analysis (PCA) identified co-reactivity patterns; real-time PCR used for environmental Bp DNA detection.

Main Results:

  • HCP1 and CPS I antigens showed highest specificity, indicating potential for targeted serological detection.
  • Mahajanga region exhibited the highest seroprevalence and co-seroprevalence for HCP1 and CPS I (p < 0.0001).
  • PCA revealed distinct immune response profiles; Bp DNA was detected in a Mahajanga water sample.

Conclusions:

  • Human exposure to Bp is confirmed across multiple regions in Madagascar.
  • HCP1 and CPS I are identified as promising targets for developing diagnostic tools.
  • Environmental Bp presence in Mahajanga highlights the need for targeted public health interventions.